Immunovant Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Apr 3, 2025 FORM 4
4 Apr 3, 2025 FORM 4
4 Apr 3, 2025 FORM 4
4 Apr 3, 2025 FORM 4
4 Apr 3, 2025 FORM 4
4 Apr 3, 2025 FORM 4
SCHEDULE 13G Mar 26, 2025
8-K Mar 19, 2025 8-K
4 Mar 11, 2025 FORM 4
144 Mar 7, 2025
SCHEDULE 13G/A Mar 7, 2025
4 Feb 21, 2025 FORM 4
4 Feb 21, 2025 FORM 4
4 Feb 21, 2025 FORM 4
144 Feb 14, 2025
144 Feb 11, 2025
10-Q Feb 6, 2025 10-Q
8-K Feb 6, 2025 8-K
8-K Jan 24, 2025 8-K
424B3 Jan 24, 2025 424B3
4 Jan 24, 2025 FORM 4
4 Jan 24, 2025 FORM 4
D Jan 21, 2025
4 Jan 17, 2025 FORM 4
4 Jan 17, 2025 FORM 4
← Newer Page 6 of 26 · 641 filings Older →